This post is the first in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions.

We had I think about 700 people last Tuesday that became owners of ario outside of the partner group. So it is a very important, and you've echoed that a couple of times, a very important part of the ...

Navigating the Committee on Foreign Investment in the United States has long been a key consideration for inbound investors to the U.S. But at the start of 2025, a new regulatory framework was ...

Dealmakers from some of the industry’s most acquisitive RIAs gathered at last week’s DeVoe M&A+ Succession Summit in Chicago to share their strategies around deal structure amid this year’s ...

One of the most dreaded replies from a professional services provider is, “it depends.” Unfortunately, that’s truly the case when determining the most optimal tax structure for your transaction. There ...

Experts point to the large transaction size, investor demand for management control and the involvement of multiple stakeholders as key factors. While similar deals in private banks have been ...